Literature DB >> 32135391

Psychiatric comorbidity in adolescent use and poly-use of combustible, vaporized, and edible cannabis products.

Adam M Leventhal1, Dayoung Bae2, Afton Kechter3, Jessica L Barrington-Trimis3.   

Abstract

Cannabis legalization and commercialization has resulted in novel alternative cannabis products on the market, including edible and vaporized cannabis, which may appeal to youth with psychiatric problems. Psychiatric comorbidity in adolescent use and poly-use (i.e., use of >2 products) of combustible, edible, and vaporized cannabis products has largely gone uninvestigated. This 2015 cross-sectional survey of Los Angeles, California area adolescents (Mage = 16.1, N = 3177) characterized associations of various psychiatric problems with use and poly-use of combustible, edible, and vaporized cannabis. Exposure variables included past 30-day non-cannabis substance use (alcohol, e-cigarettes, combustible cigarettes, and nonmedical prescription opioid and stimulant use; yes/no), and psychiatric problems including past-week depressive symptom frequency, past 6-month ADHD symptom and conduct problem frequency, anhedonia, and five dimensions of impulsivity (sensation seeking, perseverance, lack of premeditation, positive urgency, and negative urgency). Outcome variables included past 30-day use (yes/no) of combustible, edible, and vaporized cannabis, independently, and number of cannabis products used (single, dual-use, poly-use). Results showed that all forms of non-cannabis substance use (ORs range: 13.7-36.1) and all psychiatric symptoms and traits (ORs in SD units range: 1.1-2.1) were positively associated with combustible, edible, and vaporized cannabis product use. The magnitude of comorbidity did not significantly differ by cannabis product type used in most cases. Psychiatric comorbidity was typically stronger in poly-product than single-product cannabis use and greater for externalizing-type than internalizing-type psychiatric problems. Practitioners, policy makers, and scientists should be aware that pervasive psychiatric comorbidity may be observed across the spectrum of cannabis product use among adolescents, particularly poly-product users.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adolescents; Cannabis; Edible; Psychiatric comorbidity; Smoking; Vaping

Mesh:

Year:  2020        PMID: 32135391      PMCID: PMC7190202          DOI: 10.1016/j.jpsychires.2020.02.021

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  34 in total

1.  Research domain criteria (RDoC): toward a new classification framework for research on mental disorders.

Authors:  Thomas Insel; Bruce Cuthbert; Marjorie Garvey; Robert Heinssen; Daniel S Pine; Kevin Quinn; Charles Sanislow; Philip Wang
Journal:  Am J Psychiatry       Date:  2010-07       Impact factor: 18.112

2.  Psychiatric comorbidity in adolescent electronic and conventional cigarette use.

Authors:  Adam M Leventhal; David R Strong; Steve Sussman; Matthew G Kirkpatrick; Jennifer B Unger; Jessica L Barrington-Trimis; Janet Audrain-McGovern
Journal:  J Psychiatr Res       Date:  2015-11-22       Impact factor: 4.791

3.  Youth risk behavior surveillance - United States, 2009.

Authors:  Danice K Eaton; Laura Kann; Steve Kinchen; Shari Shanklin; James Ross; Joseph Hawkins; William A Harris; Richard Lowry; Tim McManus; David Chyen; Connie Lim; Lisa Whittle; Nancy D Brener; Howell Wechsler
Journal:  MMWR Surveill Summ       Date:  2010-06-04

4.  Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.

Authors:  Matthew N Newmeyer; Madeleine J Swortwood; Allan J Barnes; Osama A Abulseoud; Karl B Scheidweiler; Marilyn A Huestis
Journal:  Clin Chem       Date:  2016-10-10       Impact factor: 8.327

5.  A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale.

Authors:  R P Snaith; M Hamilton; S Morley; A Humayan; D Hargreaves; P Trigwell
Journal:  Br J Psychiatry       Date:  1995-07       Impact factor: 9.319

Review 6.  Psychiatric disease and drug abuse.

Authors:  Karen Santucci
Journal:  Curr Opin Pediatr       Date:  2012-04       Impact factor: 2.856

7.  Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence.

Authors:  Adam M Leventhal; David R Strong; Matthew G Kirkpatrick; Jennifer B Unger; Steve Sussman; Nathaniel R Riggs; Matthew D Stone; Rubin Khoddam; Jonathan M Samet; Janet Audrain-McGovern
Journal:  JAMA       Date:  2015-08-18       Impact factor: 56.272

8.  Online survey characterizing vaporizer use among cannabis users.

Authors:  Dustin C Lee; Benjamin S Crosier; Jacob T Borodovsky; James D Sargent; Alan J Budney
Journal:  Drug Alcohol Depend       Date:  2015-12-30       Impact factor: 4.492

9.  Neural Correlates of Social Influence Among Cannabis Users.

Authors:  Jodi M Gilman
Journal:  Curr Addict Rep       Date:  2017-05-08

10.  Drug vaping applied to cannabis: Is "Cannavaping" a therapeutic alternative to marijuana?

Authors:  Vincent Varlet; Nicolas Concha-Lozano; Aurélie Berthet; Grégory Plateel; Bernard Favrat; Mariangela De Cesare; Estelle Lauer; Marc Augsburger; Aurélien Thomas; Christian Giroud
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

View more
  3 in total

1.  Assessing subjective cannabis effects in daily life with contemporary young adult language.

Authors:  Renee M Cloutier; Brian H Calhoun; Stephanie T Lanza; Ashley N Linden-Carmichael
Journal:  Drug Alcohol Depend       Date:  2021-12-01       Impact factor: 4.492

Review 2.  Cannabis Vaping Among Youth and Young Adults: a Scoping Review.

Authors:  Melissa B Harrell; Stephanie L Clendennen; Aslesha Sumbe; Kathleen R Case; Dale S Mantey; Sunaina Swan
Journal:  Curr Addict Rep       Date:  2022-05-07

3.  Association of tobacco and marijuana use with symptoms of depression and anxiety among adolescents and young adults in Texas.

Authors:  Aslesha Sumbe; Anna V Wilkinson; Stephanie L Clendennen; Bara S Bataineh; Kymberle L Sterling; Baojiang Chen; Melissa B Harrell
Journal:  Tob Prev Cessat       Date:  2022-01-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.